Atoltivimab
Atoltivimab-Ebgn is an investigational monoclonal antibody cocktail designed to target the SARS-CoV-2 virus. It was being developed as a potential treatment for COVID-19, though its development status and regulatory approval may vary.
Atoltivimab-Ebgn is an investigational monoclonal antibody combination being studied for the treatment of COVID-19.
Key facts at a glance
- RxNorm
- 2461430
- Generic
- Atoltivimab-Ebgn
- Class
- pin-variant
- Brands
- Inmazeb
- Availability
- rx
- Lactation
- unknown
- Routes
- —
- Forms
- —
- Regions
- US, EU, CN, JP
- Monitoring
- —
This page is for informational purposes only.
Do not use this information to diagnose yourself or to replace a physician's advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you believe you are experiencing a medical emergency, call your local emergency number immediately.
Investigated for the treatment and prevention of COVID-19 caused by SARS-CoV-2 infection. It was not FDA-approved at the time of this knowledge cutoff.
This is a combination of two monoclonal antibodies (atoltivimab and ebgn) that bind to different regions of the SARS-CoV-2 spike protein, potentially neutralizing the virus and preventing cell entry.
This medication is investigational and not commercially available. Monoclonal antibody treatments for COVID-19 have shown variable efficacy against different variants. Healthcare providers should verify current regulatory status and availability. Patients should only receive treatments authorized or approved by relevant regulatory authorities.
Official drug label
WellAlly may earn a referral fee from linked resources at no extra cost to you. Editorial content is never influenced by commercial relationships.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 27, 2026. · Read our editorial policy